Pulmão

1 - Asma
Título: Prevalence of asthma in Portuguese adults - the EPI-ASTHMA study, a nationwide population based survey.
Pulmonology Journal | 2025
Comunicação Oral ver aqui.

2 - Asma
Título: Benralizumab Effectiveness in Biologic-Naïve and Biologic-Experienced Patients with Severe Eosinophilic Asthma: a BETREAT study analysis.
Congresso Nacional de Pneumologia | 2023
Comunicação Oral ver aqui.

3 - Asma
Título: Improvement of Clinical Outcomes in Severe Eosinophilic Asthma Patients treated with Benralizumab in Real-World Setting: BETREAT study.
Congresso Nacional de Pneumologia | 2023
Comunicação Oral ver aqui.

4 - Asma
Título: Benralizumab Effectiveness in Patients with Severe Eosinophilic Asthma, with and without Chronic Rhinosinusitis with Nasal Polyps: a BETREAT study analysis.
Congresso Nacional de Pneumologia | 2023
Comunicação Oral ver aqui.

5 - Asma
Título: Healthcare resource utilization of severe eosinophilic asthma patients treated with benralizumab in real-life: results from the Portuguese BETREAT study.
ISPOR-EU | 2023
Póster ver aqui.

6 - Asma
Título: Characteristics of oral corticosteroid users among persons with asthma on GINA step 3 therapy and above: a cross-sectional study in Portuguese community pharmacies.
Journal of Asthma & Allergy | 2022
Artigo Científico ver aqui.

7 - Asma
Título: Characteristics of Reliever Inhaler Users and Asthma Control: A Cross-Sectional Multicenter Study in Portuguese Community Pharmacies.
Journal of Asthma & Allergy | 2021
Artigo Científico ver aqui.

8 - Asma
Título: Validation of the Adult Asthma Epidemiological Score: a secondary analysis of EPI-ASTHMA.
BMJ Open Journal | 2024
Artigo Científico ver aqui.

9 - Asma
Título: EPI-Asma study protocol - a population-based multicentre stepwise study on the prevalence and characterisation of patients with Asma according to disease severity in Portugal.
BMJ Open | 2022
Artigo Científico ver aqui.

10 - Asma
Título: Prevalence and characterisation of patients with asthma according to disease severity in Portugal: Findings from the EPI-ASTHMA pilot study.
Journal of Asthma & Allergy | 2022
Artigo Científico ver aqui.

11 - Asma
Título: EPI-ASTHMA study protocol - a population-based multicentre stepwise study on the prevalence and characterisation of patients with asthma according to disease severity in Portugal.
BMJ Open | 2022
Artigo Científico ver aqui.

12 - Asma
Título: Prevalence and characterisation of patients with asthma according to disease severity in Portugal: Findings from the EPI-ASTHMA pilot study.
Journal of Asthma & Allergy | 2022
Artigo Científico ver aqui.

13 - Asma
Título: Characteristics of oral corticosteroid users among persons with asthma on GINA step 3 therapy and above: a cross-sectional study in Portuguese community pharmacies.
Journal of Asthma & Allergy | 2022
Artigo Científico ver aqui.

14 - Asma
Título: Characteristics of Reliever Inhaler Users and Asthma Control: A Cross-Sectional Multicenter Study in Portuguese Community Pharmacies.
Journal of Asthma & Allergy | 2021
Artigo Científico ver aqui.

15 - Asma
Título: Validation of the Adult Asthma Epidemiological Score: a secondary analysis of EPI-ASTHMA.
BMJ Open | 2024
Artigo Científico ver aqui.

16 - Asma
Título: Healthcare resource utilization of severe eosinophilic asthma patients treated with benralizumab in real-life: results from the Portuguese BETREAT study.
ISPOR-EU | 2023
Póster ver aqui.

17 - Asma
Título: The utility of individualized FeNO as a screening tool to rule out asthma: a secondary analysis of EPI-ASTHMA.
Congresso Nacional de Pneumologia | 2024
Comunicação Oral ver aqui.

18 - Asma
Título: Asthma impact on work productivity in Portugal: data from the EPI-ASTHMA study.
ISPOR-EU | 2024
Póster ver aqui.

19 - Cancro do Pulmão
Título: Patients' characteristics and treatment pathways in stage III non-small cell lung cancer in real life setting - Portugal (PICTURE).
Encontros da Primavera | 2021
Póster ver aqui.

20 - DPOC
Título: Risk Profiles and Impact of Moderate and Severe Exacerbations in Chronic Obstructive Pulmonary Disease.
Congresso Nacional de Pneumologia | 2023
Póster ver aqui.

Veeva ID: PT-23047 Aprovado a 01/2026